1003012-19-8

Basic information

• Product Name: 4-(3-amino-pyrazol-1-ylmethyl)-benzoic acid methyl ester
• Synonyms: 4-(3-amino-pyrazol-1-ylmethyl)-benzoic acid methyl ester
• CAS NO: 1003012-19-8
• Molecular Weight: 231.254
• Mol File: 1003012-19-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(3-amino-pyrazol-1-ylmethyl)-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-amino-pyrazol-1-ylmethyl)-benzoic acid methyl ester(1003012-19-8)
• EPA Substance Registry System: 4-(3-amino-pyrazol-1-ylmethyl)-benzoic acid methyl ester(1003012-19-8)

Safety Data

• Hazardous Substances Data: 1003012-19-8(Hazardous Substances Data)

Upstream product

• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 957513-33-6 4-(3-nitro-pyrazol-1-ylmethyl)-benzoic acid methyl ester 

Downstream Products

• 1033780-02-7 (E)-4-{3-[2-(3-chloro-4-methanesulfonyl-phenyl)-2-cyclopentyloxyimino-acetylamino]-pyrazol-1-ylmethyl}-benzamide 
• 1033780-00-5 (E)-4-{3-[2-(3-chloro-4-methanesulfonyl-phenyl)-2-cyclopentyloxyimino-acetylamino]-pyrazol-1-ylmethyl}-benzoic acid methyl ester 

Relevant articles and documents

Acetamide compounds as glucokinase activators, their process and medicinal applications

Acetamide derivatives, their stereoisomers, tautomers, prodrugs, pharmaceutically acceptable salts, polymorphs, solvates and formulations thereof for the prophylaxis, management, treatment, control of progression, or adjunct treatment of diseases and/or m

Pyrazole glucokinase activators

Disclosed herein are pyrazole glucokinase activators of the formula (I) useful for the treatment of metabolic diseases and disorders, preferably diabetes mellitus.